176 related articles for article (PubMed ID: 29260856)
1. Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin.
Iyer R; Moussa SH; Durand-Réville TF; Tommasi R; Miller A
ACS Infect Dis; 2018 Mar; 4(3):373-381. PubMed ID: 29260856
[TBL] [Abstract][Full Text] [Related]
2. Targeting Multidrug-Resistant
Barnes MD; Kumar V; Bethel CR; Moussa SH; O'Donnell J; Rutter JD; Good CE; Hujer KM; Hujer AM; Marshall SH; Kreiswirth BN; Richter SS; Rather PN; Jacobs MR; Papp-Wallace KM; van den Akker F; Bonomo RA
mBio; 2019 Mar; 10(2):. PubMed ID: 30862744
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles containing OmpA induce mitochondrial fragmentation to promote pathogenesis of Acinetobacter baumannii.
Tiku V; Kofoed EM; Yan D; Kang J; Xu M; Reichelt M; Dikic I; Tan MW
Sci Rep; 2021 Jan; 11(1):618. PubMed ID: 33436835
[TBL] [Abstract][Full Text] [Related]
4. Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.
McLeod SM; Shapiro AB; Moussa SH; Johnstone M; McLaughlin RE; de Jonge BLM; Miller AA
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133555
[TBL] [Abstract][Full Text] [Related]
5. A Multidisciplinary Approach toward Identification of Antibiotic Scaffolds for Acinetobacter baumannii.
Bhamidimarri SP; Zahn M; Prajapati JD; Schleberger C; Söderholm S; Hoover J; West J; Kleinekathöfer U; Bumann D; Winterhalter M; van den Berg B
Structure; 2019 Feb; 27(2):268-280.e6. PubMed ID: 30554842
[TBL] [Abstract][Full Text] [Related]
6. Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Isaacs RD; O'Donnell JP; Stone E
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126953
[TBL] [Abstract][Full Text] [Related]
7. OmpA is the principal nonspecific slow porin of Acinetobacter baumannii.
Sugawara E; Nikaido H
J Bacteriol; 2012 Aug; 194(15):4089-96. PubMed ID: 22636785
[TBL] [Abstract][Full Text] [Related]
8. In vivo antibacterial activity of Zataria multiflora Boiss extract and its components, carvacrol, and thymol, against colistin-resistant Acinetobacter baumannii in a pneumonic BALB/c mouse model.
Hassannejad N; Bahador A; Rudbari NH; Modarressi MH; Parivar K
J Cell Biochem; 2019 Nov; 120(11):18640-18649. PubMed ID: 31338900
[TBL] [Abstract][Full Text] [Related]
9.
McLeod SM; Moussa SH; Hackel MA; Miller AA
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988095
[No Abstract] [Full Text] [Related]
10. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
[TBL] [Abstract][Full Text] [Related]
11. Structural investigations on novel porin, OmpAb from Acinetobacter baumannii.
Vashist J; Rajeswari MR
J Biomol Struct Dyn; 2006 Dec; 24(3):243-53. PubMed ID: 17054382
[TBL] [Abstract][Full Text] [Related]
12. ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Durand-Réville TF; Guler S; Comita-Prevoir J; Chen B; Bifulco N; Huynh H; Lahiri S; Shapiro AB; McLeod SM; Carter NM; Moussa SH; Velez-Vega C; Olivier NB; McLaughlin R; Gao N; Thresher J; Palmer T; Andrews B; Giacobbe RA; Newman JV; Ehmann DE; de Jonge B; O'Donnell J; Mueller JP; Tommasi RA; Miller AA
Nat Microbiol; 2017 Jun; 2():17104. PubMed ID: 28665414
[TBL] [Abstract][Full Text] [Related]
13. Small-Molecule Transport by CarO, an Abundant Eight-Stranded β-Barrel Outer Membrane Protein from Acinetobacter baumannii.
Zahn M; D'Agostino T; Eren E; Baslé A; Ceccarelli M; van den Berg B
J Mol Biol; 2015 Jul; 427(14):2329-39. PubMed ID: 25846137
[TBL] [Abstract][Full Text] [Related]
14. Screening of small molecules attenuating biofilm formation of Acinetobacter baumannii by inhibition of ompA promoter activity.
Na SH; Jeon H; Oh MH; Kim YJ; Lee JC
J Microbiol; 2021 Sep; 59(9):871-878. PubMed ID: 34449059
[TBL] [Abstract][Full Text] [Related]
15.
Rodriguez CH; Brune A; Nastro M; Vay C; Famiglietti A
J Med Microbiol; 2020 Jul; 69(7):928-931. PubMed ID: 32584214
[No Abstract] [Full Text] [Related]
16. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection.
Nie D; Hu Y; Chen Z; Li M; Hou Z; Luo X; Mao X; Xue X
J Biomed Sci; 2020 Jan; 27(1):26. PubMed ID: 31954394
[TBL] [Abstract][Full Text] [Related]
17. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models.
Monogue ML; Sakoulas G; Nizet V; Nicolau DP
Pharmacology; 2018; 101(5-6):255-261. PubMed ID: 29533955
[TBL] [Abstract][Full Text] [Related]
18. Mutation of CarO participates in drug resistance in imipenem-resistant Acinetobacter baumannii.
Zhu LJ; Chen XY; Hou PF
J Clin Lab Anal; 2019 Oct; 33(8):e22976. PubMed ID: 31318107
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane protein a in Acinetobacter baumannii induces autophagy through mTOR signalling pathways in the lung of SD rats.
Zhao D; Li Y; Peng C; Lin J; Yu F; Zhao Y; Zhang X; Zhao D
Biomed Pharmacother; 2021 Mar; 135():111034. PubMed ID: 33388597
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
